Rutgers MTA

  • 13:11

Immunicum AB (publ) has signed a research agreement with Rutgers Cancer Institute of New Jersey, in USA to supply the institution with the Company’s adenovirus (Ad5PTDf35) technology.

Read the press release here: Press release 150907 – Rutgers Cancer Institute